Sign in

CIK 0001599298

  • Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
371979717
Phone
+1 305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 Booth Robert F. Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-01-02 Booth Robert F. Director Grant or award · Stock Option (right to buy) +7,180 $8.76 $63K 7,180
2025-01-02 Booth Robert F. Director Grant or award · Stock Option (right to buy) +35,000 35,000
2025-01-02 Booth Robert F. Director Grant or award · Stock Option (right to buy) +6,855 $9.18 $63K 6,855
2024-01-02 Booth Robert F. Director Grant or award · Stock Option (right to buy) +35,000 35,000
2024-01-02 Booth Robert F. Director Grant or award · Stock Option (right to buy) +47,651 $1.32 $63K 82,651
2023-01-03 Booth Robert F. Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-01-03 Booth Robert F. Director Grant or award · Stock Option (right to buy) +32,700 $1.67 $55K 67,700
2022-09-28 Booth Robert F. Director Grant or award · Stock Option (right to buy) +200,000 200,000
2022-09-28 Booth Robert F. Director Grant or award · Stock Option (right to buy) +6,250 206,250

Page 1 of 1 · 10 trades